Horizon, Fulcrum in gene expression research deal

Horizon Discovery Group plc (LSE:HZD) and gene control company Fulcrum Therapeutics Inc. (Cambridge, Mass.) partnered to use Horizon's CRISPR-based screening platform to identify targets for regulating gene expression. ...